Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹76,969Qualified Item Categories: Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) 43 A OKHLA INDUSTRIAL ESTATE PHASE III NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Item Categories: Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) | L1 | Qualified |
Tender Value
₹80,634.40
EMD Value
Exempted
Closing Date
14 Aug 2023, 5:00 pmClosed
Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) (Q1) ( PAC Only )
5047803
GEM/2023/B/3706599
Single Packet Bid
Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP)
GeM Contract
15 days
Uttar Pradesh; Rae Bareli
Total value wise evaluation
PRODUCT
Awarded to BIOMERIEUX INDIA PRIVATE LIMITED
₹76,969
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| HAIN LIFESCIENCE Line Probe Assay for First Line Drugs | HAIN LIFESCIENCE / GenotypeMTBDRplusV2(96Tests) | HSN not specified by seller | 1 pieces | 76,969 | 76,969 |
1 document required · 1 mandatory
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) (Q1) ( PAC Only ) | Raju Kumar 229405,All India Institute Of Medical Sciences, Munshiganj Dalmau Road, Raebareli | 1 | 15 days |
Exempted
15 Feb 2024
3 Aug 2023
14 Aug 2023
contract_GEMC-511687703552347.pdf
GEM_CONTRACT • 0.06 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5047803.pdf
GEM_BID
1691057262.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .